The impact of mindfulness on COVID-19 patients during the COVID-19 pandemic: a randomized controlled trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2021
INTERVENTION: Intervention group:Mindfulness for stress reduction;Control group:Routine care; CONDITION: Novel Coronavirus Pneumonia (COVID‐19) PRIMARY OUTCOME: Resilience; SECONDARY OUTCOME: Disease perception; INCLUSION CRITERIA: 1. Meet key diagnostic criteria for severe COVID‐19; 2. Aged between 20 and 80 years, no gender limit; 3. Stable condition, conscious and cooperative spirit in the intervention; 4. Voluntarily participate in the trial and sign the informed consent; 5. Commitment not to perform other exercise programs.
Epistemonikos ID: ffcb70a59060788a0c1e5f711563d5e93b7a1a75
First added on: Nov 30, 2021